These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Rapid improvement of depression and quality of life with escitalopram treatment in outpatients with breast cancer: a 12-week, open-label prospective trial. Park HY; Lee BJ; Kim JH; Bae JN; Hahm BJ Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):318-23. PubMed ID: 22142651 [TBL] [Abstract][Full Text] [Related]
25. A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms. Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Marangell LB Curr Med Res Opin; 2011 Oct; 27(10):1849-58. PubMed ID: 21838411 [TBL] [Abstract][Full Text] [Related]
26. Relationship between plasma concentrations of lamotrigine and its early therapeutic effect of lamotrigine augmentation therapy in treatment-resistant depressive disorder. Kagawa S; Mihara K; Nakamura A; Nemoto K; Suzuki T; Nagai G; Kondo T Ther Drug Monit; 2014 Dec; 36(6):730-3. PubMed ID: 24819973 [TBL] [Abstract][Full Text] [Related]
27. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725 [TBL] [Abstract][Full Text] [Related]
28. Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression. Baune BT; Caliskan S; Todder D Hum Psychopharmacol; 2007 Jan; 22(1):1-9. PubMed ID: 17191266 [TBL] [Abstract][Full Text] [Related]
29. Is combined treatment more effective than switching to monotherapy in patients with resistant depression? A retrospective study. Bares M; Novak T; Kopecek M; Stopkova P; Sos P Neuro Endocrinol Lett; 2009; 30(6):723-8. PubMed ID: 20038931 [TBL] [Abstract][Full Text] [Related]
30. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385 [TBL] [Abstract][Full Text] [Related]
31. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. Akiskal HS; Benazzi F; Perugi G; Rihmer Z J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694 [TBL] [Abstract][Full Text] [Related]
32. Comparison of efficacy and safety of milnacipran and fluoxetine in Korean patients with major depression. Lee MS; Ham BJ; Kee BS; Kim JB; Yeon BK; Oh KS; Oh BH; Lee C; Jung HY; Chee IS; Choe BM; Paik IH Curr Med Res Opin; 2005 Sep; 21(9):1369-75. PubMed ID: 16197655 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of adjunctive aripiprazole in patients with major depressive disorder who showed minimal response to initial antidepressant therapy. Nelson JC; Thase ME; Bellocchio EE; Rollin LM; Eudicone JM; McQuade RD; Marcus RN; Berman RM; Baker RA Int Clin Psychopharmacol; 2012 May; 27(3):125-33. PubMed ID: 22466058 [TBL] [Abstract][Full Text] [Related]
34. Relative effectiveness of adjunctive risperidone on manic and depressive symptoms in mixed mania. Singh V; Bowden CL; Mintz J Int Clin Psychopharmacol; 2013 Mar; 28(2):91-5. PubMed ID: 23238761 [TBL] [Abstract][Full Text] [Related]
35. Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects. Pae CU; Mandelli L; Kim TS; Han C; Masand PS; Marks DM; Patkar AA; Steffens DC; De Ronchi D; Serretti A Biomed Pharmacother; 2009 Mar; 63(3):228-35. PubMed ID: 18502089 [TBL] [Abstract][Full Text] [Related]
36. A pooled MADRS/IDS cross-correlation analysis: clinician and patient self-report assessment of improvement in core depressive symptoms with adjunctive aripiprazole. Reimherr FW; Martin ML; Eudicone JM; Marchant BK; Tran QV; Pikalov A; Marcus RN; Berman RM; Carlson BX J Clin Psychopharmacol; 2010 Jun; 30(3):300-5. PubMed ID: 20473067 [TBL] [Abstract][Full Text] [Related]
37. The effectiveness and safety of adjunctive aripiprazole in Taiwanese patients with antidepressant-refractory major depressive disorder: a prospective, open-label trial. Chen SJ; Hsiao YL; Shen TW; Chen ST J Clin Psychopharmacol; 2012 Feb; 32(1):56-60. PubMed ID: 22198444 [TBL] [Abstract][Full Text] [Related]
38. A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression. Dunn RT; Stan VA; Chriki LS; Filkowski MM; Ghaemi SN J Affect Disord; 2008 Sep; 110(1-2):70-4. PubMed ID: 18272230 [TBL] [Abstract][Full Text] [Related]
39. A closer look at treatment resistant depression: is it due to a bipolar diathesis? Sharma V; Khan M; Smith A J Affect Disord; 2005 Feb; 84(2-3):251-7. PubMed ID: 15708423 [TBL] [Abstract][Full Text] [Related]
40. Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy. Labiner DM; Ettinger AB; Fakhoury TA; Chung SS; Shneker B; Tatum Iv WO; Mitchell Miller J; Vuong A; Hammer AE; Messenheimer JA Epilepsia; 2009 Mar; 50(3):434-42. PubMed ID: 19016830 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]